Cavu Management, LP's Form 4 filing
Lantern Pharma Inc. (LTRN) · filed Nov 9, 2022
- Accession no.
- 0001104659-22-116667
- Filed
- Nov 9, 2022, 9:39 PM ET
- Trade date
- Nov 8, 2022
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.54M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cavu Management, LPCIK 0001813270 | 10% Owner |
| Cavu Advisors, LLCCIK 0001813310 | 10% Owner |
| BP Directors, LPCIK 0001813311 | 10% Owner |
| Kreis Leslie W.CIK 0001813316 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 8, 2022 | Common Stock | SSaleDisposed | −58,711 | $4.40 | −$258,328.4 | 271,193 | Indirect | Duplicate filing |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −100,380 | $4.40 | −$441,672 | 463,658 | Indirect | Duplicate filing |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −17,748 | $4.40 | −$78,091.2 | 71,774 | Indirect | Duplicate filing |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −132,575 | $4.40 | −$583,330 | 536,163 | Indirect | Duplicate filing |
| Nov 8, 2022 | Common Stock | SSaleDisposed | −40,586 | $4.40 | −$178,578.4 | 164,137 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.